Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 30 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Priscilla S.

Brazil

USD 30 /hr

Scientific Consultant, Writer and Editor in Immunology, Molecular Biology and Health Technology Assessment

Profile Summary

I am a biomedical scientist with a Ph.D. in Therapeutic Innovation. I worked in projects related to pre-clinical research with an emphasis on autoimmune rheumatology disorders. I also have knowledge in health technology assessment and evidence-based health areas. Recently, I have been working on the molecular diagnosis of SARS-CoV-2 by Rt-qPCR.

Subject Matter Expertise

• ★ Molecular Biology
• ★ Preclinical Research
• ☆ Biostatistics
• ☆ Immunoassay
• ☆ Cell Biology
• ☆ Drug Development
• ☆ Allergy & Clinical Immunology
• ☆ Clinical Laboratory Science
• ☆ Health Technology Assessment
• ☆ Research
• ☆ Research Methodology

Services

• Writing
• Research
• Consulting
• Data & AI

Writing Clinical Trial Documentation, Technical Writing

Research Feasibility Study, Fact Checking, Systematic Literature Review, Secondary Data Collection

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis, Data Visualization

Work Experience

Analyst and manager of the diagnosis of SARS-COV 2 by RT-qPCR

Federal University of Pernambuco

May 2020 - Present

Education

Universidade Federal de Pernambuco

March 2010 - Present

Ph.D in Therapeutic Innovation

Federal University of Pernambuco

March 2016 - November 2019

Master in Therapeutic Innovation

Federal University of Pernambuco

March 2014 - February 2016

Bachelor in Biomedicine

Federal University of Pernambuco

March 2010 - December 2013

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

(2020). Atorvastatin inhibits {IL}-17A, {TNF}, {IL}-6, and {IL}-10 in {PBMC} cultures from patients with severe rheumatoid arthritis . Immunobiology. 225. (3). p. 151908. Elsevier {BV}

(2018). Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations . Immunology Letters. 198. p. 12--16. Elsevier {BV}

(2018). Study of the Potential Radiomitigator Effect of Quercetin on Human Lymphocytes . Inflammation. 42. (1). p. 124--134. Springer Science and Business Media {LLC}

(2017). Corticosteroid inhibits chemokines production in systemic sclerosis patients . Steroids. 127. p. 24--30. Elsevier {BV}

(2016). Increased {IL}17A, {IFNG}, and {FOXP}3 Transcripts in Moderate-Severe Psoriasis: A Major Influence Exerted by {IL}17A in Disease Severity . Mediators of Inflammation. 2016. p. 1--8. Hindawi Limited

(2015). {IL}-17A, {IL}-22, {IL}-6, and {IL}-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients . Mediators of Inflammation. 2015. p. 1--5. Hindawi Limited

(2013). Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients . Clinics. 68. (6). p. 766--771. Fundacao Faculdade de Medicina

(2013). Synthesis of a Novel Thiazolidinedione and Evaluation of Its Modulatory Effect on {IFN}-$\upgamma$, {IL}-6, {IL}-17A, and {IL}-22 Production in {PBMCs} from Rheumatoid Arthritis Patients . {BioMed} Research International. 2013. p. 1--8. Hindawi Limited

(2013). Cratylia mollis1, 4 Lectin: A New Biotechnological Tool in IL-6, IL-17A, IL-22, and IL-23 Induction and Generation of Immunological Memory . BioMed Research International.